| Literature DB >> 30272171 |
Phyllis W Speiser1,2, Wiebke Arlt3, Richard J Auchus4, Laurence S Baskin5, Gerard S Conway6, Deborah P Merke7,8, Heino F L Meyer-Bahlburg9, Walter L Miller5, M Hassan Murad10, Sharon E Oberfield11, Perrin C White12.
Abstract
Objective: To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency clinical practice guideline published by the Endocrine Society in 2010. Conclusions: The writing committee presents updated best practice guidelines for the clinical management of congenital adrenal hyperplasia based on published evidence and expert opinion with added considerations for patient safety, quality of life, cost, and utilization.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30272171 PMCID: PMC6456929 DOI: 10.1210/jc.2018-01865
Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN: 0021-972X Impact factor: 5.958